Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr. Bin Sun, a Dphil graduate from the Szele Research group within the Department, has published a paper in Cerebral Cortex based on his work. 

Bin's research showed that an epigenetic modification - diminishing the multi-protein complex "polycomb repressor complex 2" (PRC2) - severely reduces SVZ neurogenesis. He showed that selectively removing extra embryonic development (Eed) affects the maintenance of stem cells in the SVZ. This was a different effect from when he removed the enhancer of zeste 2 (Ezh2) methyltransferase component of PRC2, which Bin showed works downstream in the SVZ lineage.

Based on the embryonic stem cell literature, Bin went on to hypothesize that Eed may normally suppress expression of the transcription factor Gata6 and showed that this indeed was the case. He demonstrated that Gata6 overexpression phenocopied loss of Eed and that knocking Gata6 down was sufficient to rescue Eed function. Gata6 can affect expression of a key cell cycle regulator called P21 (a cyclin-dependent kinase inhibitor). Bin elegantly showed that in the SVZ, Gata6 regulates not transcription of P21 but its post-translational stability.

Finally he showed that Eed is necessary for activating SVZ repair mechanisms in traumatic brain injury.

Thus, Bin has made several important novel discoveries that have bearing on our understanding of how adult neurogenesis is regulated.

Congratulations Dr Sun!

 

To find out more information about what the Szele Research group gets up to, visit their website page.

Similar stories

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

New insights into chemogenetic designer drugs to enhance our study of behaviour

A collaborative team of researchers in DPAG and Pharmacology led by Dr Lukas Krone have uncovered striking new data demonstrating that two widely used designer drugs used to turn populations of neurons on and off in the brain cause unexpected effects on sleep. These results demonstrate a critical need to improve chemogenetic approaches in behavioural studies.

Unlocking the Secrets of cAMP Signalling in the Heart: A Pathway to Targeted Therapeutics

A new Zaccolo group study has revealed key new insights into the role of cAMP signalling in both healthy and disease settings within the heart. They have identified new cAMP nanodomains in cardiac muscle cells that have far reaching implications for the treatment of heart disease.

Key exosome subtype in cancer progression identified

Collaborative work from DPAG and Oncology researchers has revealed a potential new pathway to block the production of a specific group of exosomes made in the cell’s recycling system that can promote the growth of cancerous tumours.

New blood test from DPAG cardiac researchers could save lives of heart attack victims

Researchers from the Herring group have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.